Gencor’s Levagen+ PEA ingredient gains traction in topicals and cosmeceuticals, firm says

Gencor (Austin, TX) reports that its palmitoylethanolamide (PEA) ingredient, called Levagen+, is being featured in more topical and cosmeceutical products, including most recently in the LYMA Skincare line. The ingredient is designed to support a healthy inflammatory response and to protect against damage from oxidative stress.

“Upscale brands like LYMA Skincare have included Levagen+ in their breakthrough skincare line to improve elasticity, reduce redness, protect against oxidative stress­–induced damage, and help slow the skin’s immunological dysregulation through the skin’s extracellular matrix (ECM),” the company’s press release states.

The company explains that PEA is an endogenous fatty acid amide that the body naturally produces when responding to injury and stress. The body’s natural production of PEA decreases with age, however, “which could allow for unbalanced levels of inflammation and a decreased immune system,” the firm says.

It adds: “Levagen+ helps target inflammaging, which refers to the chronic, low-grade inflammation associated with age-related changes in the skin. Common signs of this are uneven skin tone, dullness, fine lines, and dehydration.”

Levagen+ is made with LipiSperse delivery technology from Pharmako Biotechnologies. It is suited for products including gels, creams, effervescents, and powders.